Theravance Biopharma, Inc. Insider Trading for August 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Theravance Biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Theravance Biopharma, Inc. for August 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 23 2017 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP, Chief Comm Ops ... | Buy | P | 26.34 | 4,000 | 105,359 | 213,180 | 209.2 K to 213.2 K (+1.91 %) |
| Aug 22 2017 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 27.40 | 5,502 | 150,755 | 164,632 | 170.1 K to 164.6 K (-3.23 %) |
| Aug 22 2017 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Payment of Exercise | F | 27.40 | 7,079 | 193,965 | 148,997 | 156.1 K to 149 K (-4.54 %) |
| Aug 22 2017 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 27.40 | 5,013 | 137,356 | 152,320 | 157.3 K to 152.3 K (-3.19 %) |
| Aug 22 2017 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP, Chief Comm Ops ... | Payment of Exercise | F | 27.40 | 5,820 | 159,468 | 209,180 | 215 K to 209.2 K (-2.71 %) |
| Aug 22 2017 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Payment of Exercise | F | 27.40 | 5,176 | 141,822 | 160,137 | 165.3 K to 160.1 K (-3.13 %) |
| Aug 22 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 27.40 | 7,064 | 193,554 | 149,342 | 156.4 K to 149.3 K (-4.52 %) |
| Aug 22 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 27.40 | 6,752 | 185,005 | 214,547 | 221.3 K to 214.5 K (-3.05 %) |
| Aug 14 2017 | TBPH | Theravance Biophar ... | WHITESIDES GEORGE M | Director | Buy | P | 24.69 | 4,000 | 98,764 | 4,000 | 0 to 4 K |
| Aug 14 2017 | TBPH | Theravance Biophar ... | MALKIEL BURTON G | Director | Buy | P | 24.59 | 15,000 | 368,816 | 15,000 | 0 to 15 K |
| Aug 14 2017 | TBPH | Theravance Biophar ... | MALKIEL BURTON G | Director | Buy | P | 24.59 | 15,000 | 368,855 | 47,571 | 32.6 K to 47.6 K (+46.05 %) |
| Aug 11 2017 | TBPH | Theravance Biophar ... | Fore Henrietta | Director | Buy | P | 23.99 | 6,000 | 143,932 | 24,000 | 18 K to 24 K (+33.33 %) |
| Aug 11 2017 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Buy | P | 24.50 | 10,000 | 245,000 | 866,377 | 856.4 K to 866.4 K (+1.17 %) |
| Aug 03 2017 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Option Exercise | A | 31.93 | 170,000 | 5,428,100 | 170,000 | |
| Aug 03 2017 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |